Veteran CRO executive and investor brings more than 30 years of clinical research leadership and deep pharma networks to the Barcelona-based medical...
This post reviews QMENTA's 2025 progress in clinical imaging infrastructure, including enterprise security compliance, regulatory validation with...
Multi-site imaging clinical trials face harmonization, QC, and compliance risks. Learn proven solutions for enterprise trial teams and core labs.
Learn the 5 critical success factors clinical directors need to run multi-site neuroimaging trials—covering protocol standardization, QC, training,...
Learn the key challenges of medical AI validation and how cloud-based platforms streamline AI validation medical imaging workflows for clinical...
Academic imaging facilities face funding cuts, rising data volumes, and infrastructure costs. Learn how to rethink imaging budget management for 2026.
Imaging compliance failures often surface only during FDA inspections. Learn how documentation gaps, audit trails, and delayed QC put trials at risk.
RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
Is your imaging facility drowning in data? Spot 5 warning signs of poor imaging data management and discover solutions to transform chaos into...
Manual reviews slow studies and add risk. Learn how QMENTA automates imaging review and QC with AI workflows that adapt to any protocol.
AI pioneer Dr. John E. Kelly III shares insights on building trust, improving data, and driving progress in AI-enabled neurological trials.
Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis
Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and...
The imaging clinical trials industry continues to grow in the face of unique challenges! To help you keep up, we’ve put together the top trends to...
Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...
Advance Parkinson’s research with QMENTA's Imaging Hub: cutting-edge imaging, biomarker insights, and cloud-based tools for early detection and...
Discover how the Central Vein Sign (CVS) may enhance diagnostic accuracy, advance research outcomes, and influence the McDonald criteria.
Discover how AI enhances medical imaging workflows, boosting accuracy and efficiency. Learn benefits, challenges, and how QMENTA simplifies AI...
Take a look ahead at our predicted trends for neuroscience in 2025 - where technology, neuroplasticity, and neuroethics are reshaping the way we...
Discover insights into structural and functional aspects of the human brain, potential biomarkers, and applications in psychiatric research.
Discover Hybrid Cloud Imaging on QMENTA: merging automated & manual processes for peak accuracy in medical imaging.
Unleashing automated white matter lesion segmentation: Advancements in MS assessment. Evolving imaging techniques, revolutionizing diagnosis &...
Boston, MA, March 29, 2023— QMENTA, Inc. announced today that John E. Kelly III, PhD has been appointed to the company's Board of Advisors. Dr. Kelly...
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
Prof. Russ Hornbeck shares insights on Alzheimer's research and imaging technology through his experience in medical imaging, discussing the DIAN...
For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
The imaging clinical trials industry is growing at a fast pace. To help you keep up, we have investigated the top trends to look for in 2024!
At RSNA 2022, our team discussed the latest advances in imaging trials software, including state-of-the-art digital biomarkers algorithms.
In order to assure that QMENTA is a reliable trusted partner for managing your medical data, we follow the highest security standards.
Since the discovery of X-Rays in 1895, Radiology has been evolving rapidly. With 127 years of advancements in mind, what can we expect for its future?
Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...
The neuro tech field has sped up in recent years and staying on top of trends is becoming a must in the neuro research. Choosing the right tech when...
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
We’re thrilled to be back at RSNA 2021, and it is very fitting that it is the first in-person event we have attended since the pandemic. QMENTA has...
The importance of Data Protection and Data Integrity in Imaging Clinical Trials
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses
QMENTA CEO Vesna Prchkovska wins Gold Female Entrepreneur of the Year in the 2021 STEVIE AWARDS FOR WOMEN IN BUSINESS
Diffusion MRI (dMRI) is a vital imaging technique that provides great insight into the brain microstructure. These microstructural properties of the...
There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.
There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.
There is a huge unmet need in treating patients with brain diseases; clinical trials fail and finding effective therapies is hard.
ANNOUNCING LEADERSHIP CHANGES AT QMENTA – NEW CEO APPOINTED AND...
MARTINOS CENTER FOR BIOMEDICAL IMAGING, UNIVERSITY OF ROCHESTER, AND QMENTA...
Medical imaging in clinical trials reduces costs and improves time to market, but many biopharma companies leave these benefits on the table.
QMENTA’s AI Platform Selected for the CAVS-MS Multiple Sclerosis Biomarker...
UK neurologists publish details of mildly affected or recovering Covid-19...
Contrast-enhanced ultrasound scans revealed patterns in the lung not typically...
Quantitative computer-aided analysis of chest CT (QCT) scans can help...
Is Radiology Ready For A Post COVID-19 Imaging Surge? ...
Young and middle-aged people, barely sick with COVID-19, Are Dying...
Radiology Revenue Could Drop by Up to 70 Percent During...
Most chest x-rays of COVID-19 patients are ‘normal’ Almost...
Imaging allows clinicians to determine severity of COVID-19 According...
A new article detailing how COVID-19 effects people with MS,outlining potential risks and recommendations for people with Multiple sclerosis.
#ConquerCovid, a collaborative, time-sensitive initiative designed to help the global medical community fight the COVID-19 pandemic.
New research in @radiology_rsna reports the first presumptive case of #COVID19–associated...
Global Data-sharing Initiative Launched To Help People With MS During...
This is a dataset of 100 axial CT images. Description ...
There are 5,863 X-Ray images (JPEG) and 2 categories (Pneumonia/Normal)....
QMENTA, a leading innovator in cloud-based, AI solutions for medical imaging, today announced it is partnering with Vanderbilt University Medical...
CAPACITY is a registry of patients with COVID-19 across Europe...
To defeat the COVID-19 pandemic, there is an urgent need...
To understand the spread of the disease and who is...
COVID-19 (Coronavirus) has rapidly spread and is becoming one of the...
QMENTA Partners with mediaire to Transform Brain Research Adds AI-Powered...
Demyelination, oedema and gliosis extend MRI T2 relaxation time. Hyperintensities...
T1 weighted imaging pre-post contrast Delta T1 quantification differentiates perfused...
January 22, 2020. QMENTA announce the appointment of Rob Bancroft as their new Cheif Executive Officer.
Top 5 Imaging Trends From ECTRIMS 2019 by Pablo Villoslada,...
QMENTA is pleased to be collaborating with Harvard’s Martinos Center and the University of Rochester to support an exciting MICCAI research challenge.
QMENTA has reached another milestone, ISO 13485:2016 certification for our quality management system.
BOSTON, MA, February 6th 2019 – QMENTA – the data-driven,...
We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November...
BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035...
A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke...
Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric...
Boston: QMENTA – The innovative platform for clinical trials and...
Stroke is the 5th leading cause of death in the world with numbers reaching up to 615.000 dead in Europe, 800.000 in the US each year. Quantib and...
QMENTA was featured in an article written by Alberto Iglesias Fraga in Business Insider Spain stating 9 innovative companies using the full potential...
Stroke is one of the most common causes of death in the western world causing more than 6 million deaths per year.
We are very happy and excited to announce that QMENTA was a winner of Accenture’s HealthTech Innovation Challenge at the London Regional finals from...
QMENTA is very proud to be a winner of 2017’s Minnies competition of Aunt Minnie. From 219 semifinal candidates, the 15 winners include prominent...
Our CSO Dr. Vesna Prchkovska was invited to talk about our startup and the tech life on CODE_n blog as a female pioneer. Please find her interview...
QMENTA / Mint Labs has been selected to be a finalist on the Minnies 2017 of AuntMinnie for Best New Radiology Vendor with our “cloud-based...
We are pleased to announce that, as part of our rebranding, our brand name has been changed to QMENTA. After 4 years as Mint Labs and achieving...
Mint Labs will be exhibiting at the 2017 annual meeting of the Organization of Human Brain Mapping. We will be at booth 34. (See the floor plan) We...
Neuroimaging analysis requires a number of software, including Open-Source and Licensed tools such as: Neurodebian, FreeSurfer, ANTS, MRtrix and many...
Mint Labs’ CEO/CTO Dr. Paulo Rodrigues and CSO Dr. Vesna Prchkovska were invited to deliver keynote speeches at Brainhack Global 2017’s Spain event....
BARCELONA – December 21, 2016. As part of the European Union’s Horizon 2020 Programme, every year the Open Data Incubator for Europe (ODINE) selects...
December 20, 2016. Anna Cabanillas interviewed our executive team to find out more about one of the most innovative companies of Barcelona. Our CEO...
BARCELONA – November 29, 2016. The need for advanced analytics of neuroimages augments each day with the increasing prevalence of...
Our Co-Founder and CSO Vesna Prckovska was invited to the European Commission and the European Parliament’s “Science is wonder-ful!” European...
Mint Labs wins DemoDiscrupt, Los Angeles Vesna Prčkovska, CSO and Co-Founder of Mint Labs, won the competition at DemoDisrupt with her pitch. The...
Paulo Rodrigues gives a talk at TED x Oporto in Portugal This year’s TEDxOporto focused on ENIGMA that arises people’s various feelings such as...
Marc Ramos Bruach was awarded at the Brain-Art Competition 2016 for their Neuroimaging visualization works. The competition has been held since 2011...
David Moreno-Dominguez, Neuroimaging Engineer at Mint Labs, gave a demo at Health 2.0, which is a worldwide movement of showcasing cutting-edge...
On March the 16th, Mint Labs was invited to make a presentation at the “Institució Cultural del CIC”. The conference room was full of young high...
Mint Labs holds the first open day event, “Hack the brain!” We invited guests to discuss neuroimaging and big data technology. It was interesting...
Every year since 1995, the “Asociación Catalana de Ingenieros de Telecomunicación” (Telecos.cat) and the “Colegio Oficial de Ingeniería en...
At Mint Labs we like challenges. Our team is always willing to discuss complex problems. We face different problems every day that challenge us and...
Vesna Prčkovska, the co-founder and CSO of Mint Labs, gives a talk at DataBeers The (Big?) Data from the Brain Vesna illustrated how neuroimaging and...
We honorably announce the addition of our new advisors, Walter Gilbert, PhD, Biotechnology/ business advisor and Michael Fox, MD, PhD, and an advisor...
Vesna Prchkovska selected as a Marie Skłodowska-Curie actions (MSCA) IF fellow of the week Vesna Prchkovska, the co-founder and Chief Science Officer...
On 22nd of October, a very interesting partnership with Bayer, Barcelona was published. Mint Labs has joined Grants4Apps, a program oriented to...
Last Sunday’s edition of the El Mundo (one of Spain’s newspapers of record, the 2nd largest) included Mint Labs in their Innovation supplement. The...
Neuroimaging cloud innovator Mint Labs announces an equity crowdfunding round with Capital Cell – to accelerate product development and growth,...
NeuroLaunch is the leading accelerator program for neuroscience startup companies. Last 24th of August was the 2nd NeuroLaunch Demo day, in Atlanta,...
Wearables, Big Data, virtual reality, 3D printing … are many emerging technologies that are being taken into the health sector by the hands of daring...
cat.economica – Mint Labs, the ‘Google Maps’ of the brain Mint Labs is featured in the Catalan economic news site cat.economica It starts with a...
Based in Madrid, freelance content strategy and branding consultant Jennifer Allerson has contributed a guest post to highlight the growth of the...
A leading economic newspaper recently wrote about Mint Labs and our expansion into the US market. The following text is a rough translation: The...
Sucessfully passed to 2nd phase FICHe grant for novel work on Quantification and Analytics for Parkinson’s disease Mint Labs’ team is happy to...
Mint Labs at Neurolaunch’s Demo Day The number of startup accelerators is doubling every year, but few are as specialized as Atlanta’s NeuroLaunch,...
CHARTING YOUR CAREER? PERSONAL STORIES ON ACADEMIC AND INNOVATION CAREERS event happened yesterday 19th of November, at the Grand hotel Central...
Dr. Vesna Prckovska in the News http://www.dnevnik.mk/?ItemID=B3A72DA281490B4D99467F1F245BDED1
Mint Labs emerges as the winner at the biotech field in The South Summit Mint Labs emerged as the winner in the biotech field in The South Summit,...
MIT Technology Review Innovators Under 35 MIT Technology Review recognized for the fourth consecutive year to 10 young innovators with the most...
CloudN© facilitates advanced medical image analysis, data management and collaboration through a cloud platform supporting unlimited storage and...
From 10 to 14 of March, Hannover (Germany) gathered 50 companies from all over the world focused on the usage and processing of big amounts of data –...
The Crown Prince of Spain visits Wayra Barcelona On Wednesday, 4 December, Crown Prince Felipe of Spain, together with Cesar Alierta, President of...
Mint Labs is proudly part of a specialized network of clinicians and researchers – Connecting the Growing Brain network. The study of the brain and...
Mint Labs wins the 3rd prize at the Cre@tic prizes from Tecnocampus, Mataro Premis Cre@tic (12ena edició), que organitza la Fundació TecnoCampus...